Medicine:Cypher stent
From HandWiki
Short description: Type of drug-eluting stent
Cypher is a brand of drug-eluting coronary stent from Cordis Corporation, a Cardinal Health company. During a balloon angioplasty, the stent is inserted into the artery to provide a "scaffold" to open the artery. An anti-rejection-type medication, sirolimus, helps to limit the overgrowth of normal cells while the artery heals which reduces the chance of re-blockage in the treated area known as restenosis, and reduces the chances that another procedure is required.[1][2]
The Cypher stent was approved for use by the FDA in 2003.[2] Following claims of inconsistent manufacturing processes and poor sales, Johnson & Johnson have announced that it will stop selling Cypher stents by the end of 2011.[3]
See also
References
- ↑ "Learn about CYPHER Stent, the latest advance in stent technology". Cordis Corporation. http://www.cypherusa.com/cypher-j2ee/cypherjsp/about/about_the_cypher_stent.jsp. Retrieved 2008-04-01.
- ↑ 2.0 2.1 "CYPHER™ Sirolimus-eluting Coronary Stent - P020026". U.S. Food and Drug Administration. https://www.fda.gov/MedicalDevices/ProductsandMedicalProcedures/DeviceApprovalsandClearances/Recently-ApprovedDevices/ucm082499.htm.
- ↑ "J&J to quit struggling heart stent business". Reuters. 2011-06-15. https://www.reuters.com/article/us-johnsonandjohnson-idUSTRE75E2PK20110615. Retrieved 2011-07-18.
 |  |
